Behavioral Health Group - BHG’s Post

This final rule modifies and updates certain provisions of regulations related to Opioid Treatment Program (OTP) accreditation, certification, and standards for the treatment of Opioid Use Disorder (OUD) with Medications for Opioid Use Disorder (MOUD) in OTPs. This includes making flexibilities put forth during the COVID-19 Public Health Emergency (PHE) permanent, as well as expanding access to care and evidence-based treatment for OUD. The final rule also removes all language and rules pertaining to the Drug Addiction and Treatment Act (DATA) Waiver from the regulations pursuant to the “Consolidated Appropriations Act, 2023”. 🥳

After more than two decades, SAMHSA and its CSAT is revisiting regulations governing OTPs, as required by the 2023 Consolidated Appropriations Act passed by Congress. HMA hosted a 3-part webinar series on the effect of proposed regulations on delivery of opioid treatment services. The series, New Rules in Treatment of Opioid Addiction, was aimed at helping stakeholders prepare for and adapt to these changes to ensure a successful transition for the people they serve. Read more and watch the series: https://lnkd.in/gjzs2GQD

Did you know attorneys general regularly collaborate with federal, state, and local health partners to address substance use issues? In 2022, NAAG and its members advocated for the Mainstreaming Addiction Treatment (MAT) Act, which removes barriers for healthcare workers to treat opioid use disorder. Learn more about the continued efforts of attorneys general to address opioid use: https://lnkd.in/gp_inBUw

Wonderful to see Mass General Brigham’s senior medical director for substance use disorder Sarah Wakeman narrating and informing this important video on #opioid dependency. Medication for opioid use disorder is an important tool towards #recovery, but ongoing stigma makes it difficult for people to access these lifesaving treatments. This is compounded by racial and economic health inequities. It’s essential that we make life saving treatments accessible for every patient that needs them. Mass General Brigham Bridge Clinics provide on-demand, compassionate care to patients at all stages of addiction. These transitional clinics work to engage and stabilize high-risk patients before connecting them to long-term, community-based care. Through concerted efforts and the support of our United Against Racism initiative, in the past year Mass General Brigham has increased access to substance use disorder care by 47% among Black patients, 111% among Latine patients and 90% among non-English speaking patients. To address the continued #SUD crisis, it’s vital that as #healthcare providers and #healthequity champions, we act as critical listeners and learn from impacted communities, spread awareness, and reduce stigma. https://lnkd.in/eFTebR4B

Are you aware the the Joint Commission revised their accreditation eligibility criteria for Opioid Treatment Programs? These revisions hold significance importance to Hospitals and Behavioral Health Care organizations with OTP programs. Check it out in the months's Barrins & Associates blog post!

Greetings to Our Colleagues in Behavioral Health! It's that time of the year again - time for another Barrins & Associates compliance topics blog post! Did you know that the Joint Commission recently revised its accreditation eligibility criteria for opioid treatment programs (OTPs)? If not, don't worry! We cover these revisions and what this means for you. You can access the blog here: https://lnkd.in/d4v_niPD

The December Barrins & Associates, an HBS Company Compliance Blog Post is here! Check out the blog to find out about the newly revised Joint Commission accreditation eligibility criteria for opioid treatment programs and much more: https://lnkd.in/d4v_niPD

Out in today's New England Journal of Medicine: A video we made for patients & families seeking care for themselves or a loved one with opioid addiction. We have effective treatments to help folks to stay safe, enter into recovery & live joyful, fulfilling lives. Learn more in the link. Thanks to StoryMine & NEJM Group for weaving this beautiful story and helping us get this message out widely. #healthcare #mentalhealth #medicine

As we continue to talk about the urgent need to expand access to methadone - the "gold standard" treatment for long-term opioid use disorder - one worry we hear about is "diversion." That's "selling or giving your methadone to someone else," to you and me. Some worry that allowing addiction medicine docs to Rx methadone, and pharmacies to dispense it, could result in more diversion. I am thrilled by this panel of smart, compassionate, pragmatic folks who will help us separate fact from fiction, and talk about the balance of methadone diversion concerns vs. the HUGE methadone access gap today that is keeping so so many people from lifesaving treatment. Join us (for free) and please share! The brilliant Stacey McKenna, Noa Krawczyk, Samuela Manages, Paul Joudrey, and Aaron Ferguson (who I somehow can't tag) are going to take us all to school. https://lnkd.in/gxGbQ_x4